Detalhe da pesquisa
1.
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long-term clinical outcome of classic infantile Pompe patients.
J Inherit Metab Dis
; 43(6): 1243-1253, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32506446
2.
High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement Therapy.
J Pediatr
; 195: 236-243.e3, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29428273
3.
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain.
Dev Med Child Neurol
; 60(6): 579-586, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29573408
4.
Cat scratches or flea feces?
J Pediatr
; 164(1): 210-210.e1, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24094762
5.
Cardiac outcome in classic infantile Pompe disease after 13â¯years of treatment with recombinant human acid alpha-glucosidase.
Int J Cardiol
; 269: 104-110, 2018 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049495
6.
Cognitive decline in classic infantile Pompe disease: An underacknowledged challenge.
Neurology
; 86(13): 1260-1, 2016 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26944269